Cargando…
Classifications within Molecular Subtypes Enables Identification of BRCA1/BRCA2 Mutation Carriers by RNA Tumor Profiling
Pathogenic germline mutations in BRCA1 or BRCA2 are detected in less than one third of families with a strong history of breast cancer. It is therefore expected that mutations still remain undetected by currently used screening methods. In addition, a growing number of BRCA1/2 sequence variants of u...
Autores principales: | Larsen, Martin J., Kruse, Torben A., Tan, Qihua, Lænkholm, Anne-Vibeke, Bak, Martin, Lykkesfeldt, Anne E., Sørensen, Kristina P., Hansen, Thomas v. O., Ejlertsen, Bent, Gerdes, Anne-Marie, Thomassen, Mads |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3660328/ https://www.ncbi.nlm.nih.gov/pubmed/23704984 http://dx.doi.org/10.1371/journal.pone.0064268 |
Ejemplares similares
-
RNA profiling reveals familial aggregation of molecular subtypes in non-BRCA1/2 breast cancer families
por: Larsen, Martin J, et al.
Publicado: (2014) -
Non-BRCA1/BRCA2 high-risk familial breast cancers are not associated with a high prevalence of BRCAness
por: Andersen, Lars v. B., et al.
Publicado: (2023) -
Identification of a Danish breast/ovarian cancer family double heterozygote for BRCA1 and BRCA2 mutations
por: Steffensen, Ane Y., et al.
Publicado: (2010) -
Breast cancer survival in Nordic BRCA2 mutation carriers—unconventional association with oestrogen receptor status
por: Olafsdottir, Elinborg J., et al.
Publicado: (2020) -
Evaluation of Nine Somatic Variant Callers for Detection of Somatic Mutations in Exome and Targeted Deep Sequencing Data
por: Krøigård, Anne Bruun, et al.
Publicado: (2016)